Clinicopathological and molecular characteristics of early-onset stage III colon adenocarcinoma: An analysis of 25 studies with 35,713 patients in the Adjuvant Colon Cancer End Points (ACCENT) database.

Authors

null

Zhaohui Jin

Division of Medical Oncology, Mayo Clinic, Rochester, MN

Zhaohui Jin , Jesse G. Dixon , Hiral Parekh , Frank A. Sinicrope , Greg Yothers , Daniel G. Haller , Hans Schmoll , Aimery De Gramont , Rachel Kerr , Julien Taieb , Eric Van Cutsem , Chris Twelves , Leonard B. Saltz , Naohiro Tomita , Takayuki Yoshino , Thierry Andre , Amit Mahipal , Richard M. Goldberg , Thomas J. George , Qian Shi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3597)

DOI

10.1200/JCO.2021.39.15_suppl.3597

Abstract #

3597

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).

Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).

First Author: Temidayo Fadelu

First Author: Changying Guo